RS
Insider
Richard Scott Struthers
President & CEORichard Scott Struthers (President & CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $822K of CRNX (21,981 sh across 2 lots, as filed), executed Mar 16.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$822K
shares × price, as filed
Last traded
Mar 16
Filed Mar 18
Median ADV $326.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
CRNXRecent filings
CRNXSALE
Crinetics Pharmaceuticals, Inc.
View filing →
$822K21,981 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $180K
4,000 sh × $45.00
Exec Sep 26 2025
Filed Sep 30 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $563K
16,463 sh × $34.17
Exec Mar 19 2025
Filed Mar 21 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $576K
10,000 sh × $57.57
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET